Seaport Therapeutics, Inc. (SPTX) EBITDA
Seaport Therapeutics, Inc. (SPTX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$65.81M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$27.54M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$18.47M; Depreciation and amortization (m).
- 2025-03-31: Basis Reported; EBITDA (m); Operating income -$16.18M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$65.81M | (m) | (m) | (m) | $0.00* | -$26.14M* | (m) | $24.62M | (m) | $251.00K |
|---|
| 2026-03-31 | Reported | (m) | -$27.54M | (m) | (m) | (m) | $0.00 | -$20.17M | (m) | $21.43M | (m) | $519.00K |
|---|
| 2025-06-30 | Reported | (m) | -$18.47M | (m) | (m) | (m) | $269.00K* | -$15.32M* | (m) | $13.41M | (m) | $134.00K |
|---|
| 2025-03-31 | Reported | (m) | -$16.18M | (m) | (m) | (m) | $54.00K | -$20.20M | (m) | $10.53M | (m) | $31.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|